Eczema and race as combined determinants for differential response to step-up asthma therapy

J Allergy Clin Immunol. 2014 Aug;134(2):483-5. doi: 10.1016/j.jaci.2014.03.039. Epub 2014 May 13.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetates / therapeutic use*
  • Adolescent
  • Albuterol / analogs & derivatives*
  • Albuterol / therapeutic use
  • Androstadienes / therapeutic use*
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / complications
  • Asthma / drug therapy*
  • Asthma / ethnology
  • Asthma / pathology
  • Black or African American
  • Child
  • Cross-Over Studies
  • Cyclopropanes
  • Drug Combinations
  • Drug Monitoring
  • Eczema / complications
  • Eczema / drug therapy*
  • Eczema / ethnology
  • Eczema / pathology
  • Female
  • Fluticasone
  • Fluticasone-Salmeterol Drug Combination
  • Hispanic or Latino
  • Humans
  • Male
  • Quinolines / therapeutic use*
  • Sulfides
  • White People

Substances

  • Acetates
  • Androstadienes
  • Anti-Asthmatic Agents
  • Cyclopropanes
  • Drug Combinations
  • Fluticasone-Salmeterol Drug Combination
  • Quinolines
  • Sulfides
  • Fluticasone
  • montelukast
  • Albuterol